I’m Emily Layton.
A Science Communication enthusiast.
Hi, I'm Emily.
Lorem ipsum dolor sit amet, cons ctetur adipisng elit, seled do eiumod tempor incidnt uhgt labore reliut dolore magna aliqua.
SCIENCE
Research Experience
2016-2020
Undergraduate Researcher
Dr. Seth Bordenstein’s Lab at Vanderbilt University, Nashville, TN
More Info
Funded by SyBBURE Research Program and NSF’s Tennessee Louis Stokes Alliance for Minority Participation in Research
• Discovered a novel influence on cytoplasmic incompatibility strength and uncovered Wolbachia density and transmission dynamics in Drosophila females (independent project, Layton et al. 2019, mBio)
• Identified the Wolbachia gene responsible for rescue of cytoplasmic incompatibility (coauthored Shropshire et al. 2018, PNAS)
• Elucidated the Wolbachia genes responsible for cytoplasmic incompatibility (coauthored LePage et al. 2017, Nature)
May 2019
Research Intern
ImmunoBiochem Corporation of Johnson & Johnson’s JLABS, Toronto, Ontario, CN
Investigated the advantages and complications of current CAR-T immunotherapies in
overcoming solid tumor heterogeneity and tumor penetration.
2016-2020
Undergraduate Researcher
Dr. Seth Bordenstein’s Lab at Vanderbilt University, Nashville, TN
Funded by SyBBURE Research Program and NSF’s Tennessee Louis Stokes Alliance for Minority Participation in Research
• Discovered a novel influence on cytoplasmic incompatibility strength and uncovered Wolbachia density and transmission dynamics in Drosophila females (independent project, Layton et al. 2019, mBio)
• Identified the Wolbachia gene responsible for rescue of cytoplasmic incompatibility (coauthored Shropshire et al. 2018, PNAS)
• Elucidated the Wolbachia genes responsible for cytoplasmic incompatibility (coauthored LePage et al. 2017, Nature)
May 2019
Research Intern
ImmunoBiochem Corporation of Johnson & Johnson’s JLABS, Toronto, Ontario, CN
Investigated the advantages and complications of current CAR-T immunotherapies in
overcoming solid tumor heterogeneity and tumor penetration.
2016-2020
Undergraduate Researcher
Dr. Seth Bordenstein’s Lab at Vanderbilt University, Nashville, TN
Funded by SyBBURE Research Program and NSF’s Tennessee Louis Stokes Alliance for Minority Participation in Research
• Discovered a novel influence on cytoplasmic incompatibility strength and uncovered Wolbachia density and transmission dynamics in Drosophila females (independent project, Layton et al. 2019, mBio)
• Identified the Wolbachia gene responsible for rescue of cytoplasmic incompatibility (coauthored Shropshire et al. 2018, PNAS)
• Elucidated the Wolbachia genes responsible for cytoplasmic incompatibility (coauthored LePage et al. 2017, Nature)
May 2019
Research Intern
ImmunoBiochem Corporation of Johnson & Johnson’s JLABS, Toronto, Ontario, CN
Investigated the advantages and complications of current CAR-T immunotherapies in
overcoming solid tumor heterogeneity and tumor penetration.